Net Cash Provided by (Used in) Financing Activities in USD of AVANOS MEDICAL, INC. from 2012 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Avanos Medical, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2012 to Q1 2025.
  • Avanos Medical, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$29.1M, a 4057% decline year-over-year.
  • Avanos Medical, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$49.1M, a 47.9% increase from 2023.
  • Avanos Medical, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$94.2M, a 266% decline from 2022.
  • Avanos Medical, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $56.7M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

AVANOS MEDICAL, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$29.1M -$28.4M -4057% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 -$700K +$21.4M +96.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 -$22.1M -$128M -121% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $106M +$106M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 -$200K -$200K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $0 +$1.7M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 -$1.7M +$35M +95.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 -$36.7M -$37.2M -7440% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 $500K +$500K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q1 2016 $0 +$1M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q1 2015 -$1M +$25.1M +96.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 -$26.1M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05

AVANOS MEDICAL, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$49.1M +$45.1M +47.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 -$94.2M -$151M -266% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 $56.7M +$112M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 -$55.3M +$14.7M +21% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 -$70M -$71.5M -4767% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $1.5M +$326M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 -$324M -$327M -14845% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $2.2M +$3.6M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 -$1.4M +$49.2M +97.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 -$50.6M -$79.8M -273% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $29.2M +$209M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 -$180M -$46.1M -34.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 -$134M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.